Ansell, CathRX, CSL, Primary Health Care, Sirtex, Living Cell Technologies, Biota, Cochlear [ + ]

Enables new animal models for understanding disease and conducting drug development. [ + ]

Mesoblast to apply for regulatory approval of its bone fracture repair products. [ + ]

One-off drug delivery could dramatically improve treatment of Australia’s number one killer. [ + ]

The Australian Stem Cell Centre announces new funding scheme with four areas of emphasis. [ + ]

Cochlear, Fisher & Paykel, Ramsay, ResMed, Sigma, Sonic Health Care, Primary Health Care [ + ]

Cell division find prompts overhaul of immune response modelling. [ + ]

New chief commercial officer and senior vice president appointed ahead of omacetaxine launch in 2010. [ + ]

The manufacturer of Turbiscan suspension stability instrumentation, Formulaction, is being represented in Australia by Scientific Solutions.

Ansell, Cochlear, OMI, CSL, Ramsay, Sonic Health Care, Cellestis, Sirtex [ + ]

A new functional genomics facility has opened at Melbourne’s Peter MacCallum Cancer Centre, offering siRNA and shRNA approaches to gene silencing to Australian researchers. [ + ]

The Analytical Chemistry Group of the New South Wales branch of the RACI is holding a one-day seminar — What’s New in Laboratory Instrumentation — on 21 July 2009.

BioProspect initiates study of Bioeffective A to treat common gastric problem in horses. [ + ]

Element 112's existence has been officially confirmed by the International Union of Pure and Applied Chemistry and now the name 'copernicium' (Cp) has been proposed as its name.

Clinuvel announces positive results in Phase II Solar Urticaria study. [ + ]